Vaxcyte (PCVX) News Today → Democrats’ “break glass for emergency” candidate for 2024 (From The Freeport Society) (Ad) Free PCVX Stock Alerts $74.01 +0.08 (+0.11%) (As of 06/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 13 at 9:19 PM | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Purchased by Parkman Healthcare Partners LLCParkman Healthcare Partners LLC increased its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 267,594 shares of the company's stock afteJune 11 at 10:38 PM | marketbeat.comBraidwell LP Reduces Stake in Vaxcyte, Inc. (NASDAQ:PCVX)Braidwell LP cut its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 20.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,289,965 shares of the company's stock after sellJune 10, 2024 | marketbeat.comKynam Capital Management LP Sells 300,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Kynam Capital Management LP decreased its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 23.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,002,407 shares of the company's stock after selling 300,000 shares during the period. Vaxcyte compriJune 9, 2024 | marketbeat.comVestal Point Capital LP Purchases New Position in Vaxcyte, Inc. (NASDAQ:PCVX)Vestal Point Capital LP purchased a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 525,000 shares of the company's stock, valued at approximately $3June 8, 2024 | marketbeat.comSectoral Asset Management Inc. Has $506,000 Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Sectoral Asset Management Inc. cut its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 93.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,050 shares of the company's stock after selling 113,180 shares during the period. SectoJune 7, 2024 | americanbankingnews.comGrant Pickering Sells 2,616 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) StockJune 7, 2024 | americanbankingnews.comJim Wassil Sells 3,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) StockJune 7, 2024 | americanbankingnews.comHalley E. Gilbert Sells 18,200 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) StockJune 6, 2024 | marketbeat.comCapital Research Global Investors Purchases 75,980 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Capital Research Global Investors boosted its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,440,107 shares of the company's stock after acquiring anJune 6, 2024 | insidertrades.comVaxcyte, Inc. (NASDAQ:PCVX) SVP Mikhail Eydelman Sells 1,667 SharesJune 5, 2024 | marketbeat.comInsider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) SVP Sells 1,667 Shares of StockVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) SVP Mikhail Eydelman sold 1,667 shares of the firm's stock in a transaction that occurred on Monday, June 3rd. The stock was sold at an average price of $72.06, for a total transaction of $120,124.02. Following the sale, the senior vice president now directly owns 31,161 shares in the company, valued at approximately $2,245,461.66. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.June 4, 2024 | marketbeat.comTD Asset Management Inc Grows Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)TD Asset Management Inc grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 10.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 167,036 shares of the company's stock after buying an addiJune 3, 2024 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by UBS Group AGUBS Group AG lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 123.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 166,034 shares of the company's stock after acquiring an additional 91,May 30, 2024 | insidertrades.comGrant Pickering Sells 15,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) StockMay 29, 2024 | marketbeat.comMonashee Investment Management LLC Invests $2.36 Million in Vaxcyte, Inc. (NASDAQ:PCVX)Monashee Investment Management LLC purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 37,500 shares of the company's stock,May 29, 2024 | insidertrades.comVaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $1,041,450.00 in StockMay 28, 2024 | marketbeat.com915,512 Shares in Vaxcyte, Inc. (NASDAQ:PCVX) Purchased by Norges BankNorges Bank purchased a new position in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 915,512 shares of the company's stock, valued at approximately $57,494May 26, 2024 | marketbeat.comWestfield Capital Management Co. LP Buys 451,677 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Westfield Capital Management Co. LP grew its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 45.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,455,593 shares of the company's stock after buyingMay 25, 2024 | marketbeat.comFranklin Resources Inc. Raises Position in Vaxcyte, Inc. (NASDAQ:PCVX)Franklin Resources Inc. lifted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,076,920 shares of the company's stock after purchasingMay 23, 2024 | insidertrades.comInsider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CFO Sells 8,000 Shares of StockMay 22, 2024 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) CFO Sells $599,920.00 in StockVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the firm's stock in a transaction that occurred on Monday, May 20th. The shares were sold at an average price of $74.99, for a total transaction of $599,920.00. Following the transaction, the chief financial officer now directly owns 95,679 shares in the company, valued at approximately $7,174,968.21. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.May 19, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Raises Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX)Charles Schwab Investment Management Inc. grew its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 2.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 730,438 shares of the comMay 17, 2024 | marketbeat.comNatixis Advisors L.P. Invests $881,000 in Vaxcyte, Inc. (NASDAQ:PCVX)Natixis Advisors L.P. purchased a new position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 14,035 shares of the company's stock, valued at approximately $88May 16, 2024 | marketbeat.comVaxcyte (NASDAQ:PCVX) Trading 5.5% Higher Vaxcyte (NASDAQ:PCVX) Trading 5.5% HigherMay 15, 2024 | marketbeat.comNicholas Investment Partners LP Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Nicholas Investment Partners LP lessened its stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 75.9% in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 110,723 shares of the company's stock after selling 349,285 shares during tMay 10, 2024 | finance.yahoo.comVaxcyte Inc (PCVX) Reports Q1 2024 Earnings: A Detailed Financial and Operational OverviewMay 10, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Vaxcyte Amid Financial Discipline and Promising Vaccine TrialsMay 9, 2024 | markets.businessinsider.comBuy Rating Affirmed for Vaxcyte Amid Promising Pipeline and Clear MilestonesMay 9, 2024 | marketbeat.comVaxcyte (NASDAQ:PCVX) Releases Earnings Results, Beats Estimates By $0.28 EPSVaxcyte (NASDAQ:PCVX - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.85) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.13) by $0.28.May 9, 2024 | marketbeat.comVaxcyte (NASDAQ:PCVX) Stock Rating Reaffirmed by Cantor FitzgeraldCantor Fitzgerald reiterated an "overweight" rating on shares of Vaxcyte in a research report on Thursday.May 9, 2024 | marketbeat.comVictory Capital Management Inc. Has $23.83 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX)Victory Capital Management Inc. reduced its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 12.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 379,407 shares of the company's stock afterMay 8, 2024 | investorplace.comPCVX Stock Earnings: Vaxcyte Beats EPS for Q1 2024May 8, 2024 | globenewswire.comVaxcyte Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 4, 2024 | finance.yahoo.comInsider Sale at Vaxcyte Inc: COO Jim Wassil Sells 3,000 SharesApril 26, 2024 | marketbeat.comabrdn plc Takes $12.20 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX)abrdn plc acquired a new stake in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 194,232 shares of the company's stock, valued at approximately $12,198,000. abrdn plc ownedApril 26, 2024 | insidertrades.comInsider Selling: Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells 15,000 Shares of StockApril 25, 2024 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $928,800.00 in StockVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CEO Grant Pickering sold 15,000 shares of the company's stock in a transaction that occurred on Tuesday, April 23rd. The shares were sold at an average price of $61.92, for a total value of $928,800.00. Following the completion of the transaction, the chief executive officer now directly owns 477,847 shares in the company, valued at approximately $29,588,286.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.April 24, 2024 | finance.yahoo.comVaxcyte, Inc. (PCVX) Stock Price, News, Quote & History - Yahoo FinanceApril 24, 2024 | investing.comVaxcyte president and CFO sells shares worth over $490kApril 23, 2024 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Shares Sold by Jennison Associates LLCJennison Associates LLC reduced its position in Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 15.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 1,476,154 shares of the company's stock after selling 278,537 shares during the period. Jennison Associates LLC ownApril 22, 2024 | marketbeat.comAndrew Guggenhime Sells 8,000 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) StockVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the stock in a transaction that occurred on Thursday, April 18th. The stock was sold at an average price of $61.27, for a total transaction of $490,160.00. Following the completion of the sale, the chief financial officer now directly owns 95,679 shares of the company's stock, valued at $5,862,252.33. The transaction was disclosed in a filing with the SEC, which is available at this link.April 21, 2024 | finance.yahoo.comVaxcyte, Inc. (PCVX)April 19, 2024 | marketbeat.comMutual of America Capital Management LLC Acquires New Shares in Vaxcyte, Inc. (NASDAQ:PCVX)Mutual of America Capital Management LLC acquired a new stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 48,330 shares of the company's stock, valued at aApril 14, 2024 | nasdaq.comValidea Detailed Fundamental Analysis - PCVXApril 10, 2024 | msn.comVaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst SaysApril 2, 2024 | globenewswire.comVaxcyte to Present at the 23rd Annual Needham Virtual Healthcare ConferenceMarch 29, 2024 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by AnalystsVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) has earned an average recommendation of "Buy" from the five brokerages that are covering the company, MarketBeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that haveMarch 27, 2024 | marketbeat.comVaxcyte, Inc. (NASDAQ:PCVX) CEO Grant Pickering Sells 15,000 SharesVaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction on Monday, March 25th. The stock was sold at an average price of $66.93, for a total value of $1,003,950.00. Following the sale, the chief executive officer now directly owns 477,847 shares of the company's stock, valued at approximately $31,982,299.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.March 25, 2024 | marketbeat.comVanguard Group Inc. Buys 47,872 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)Vanguard Group Inc. boosted its stake in shares of Vaxcyte, Inc. (NASDAQ:PCVX - Free Report) by 0.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,284,246 shares of the company's stockMarch 20, 2024 | finance.yahoo.comInsider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address "The Biggest Drug Ever" Is Coming (Ad)UBS bank predicts it will become "The Biggest Drug Ever." The Wall Street Journal believes it will be "Pharma's biggest blockbuster yet." Bank of America predicts it will be the world's first "$100 billion dollar a year drug." And Morgan Stanley predicts 250 million prescriptions will be written each year. Get the name of the stock here >>> PCVX Media Mentions By Week PCVX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PCVX News Sentiment▼1.460.88▲Average Medical News Sentiment PCVX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PCVX Articles This Week▼93▲PCVX Articles Average Week Get Vaxcyte News Delivered to You Automatically Sign up to receive the latest news and ratings for PCVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Scholar Rock News Today Editas Medicine News Today Adverum Biotechnologies News Today Sangamo Therapeutics News Today Atara Biotherapeutics News Today BioNTech News Today argenx News Today Neurocrine Biosciences News Today Bio-Techne News Today Qiagen News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PCVX) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredLike Investing in Big Tech in the Early 2000s?More than a decade after the first Bitcoin was mined, people are finally realizing something very important......Manward Press | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | SponsoredMoonshot Coins for the Current Crypto RunAre you monitoring 13,217 cryptocurrencies everyday? If not, you could miss the ONE that can make you wealt...Crypto 101 Media | Sponsored